2BB score and signals
Citius Oncology, Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 18 | Very Low |
| Momentum | 45 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 20 | Weak |
| Risk | 53 | Moderate |
Company facts
| Headquarters | Cranford, New Jersey, United States |
| Founded | 2021 |
| 52-week range | $0.49 – $2.25 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-11 | — | 0.0 | — | $14.56M |
| 2026-12-21 | — | -0.2142 | — | $5.89M |
| 2026-08-18 | — | -0.051 | — | $2.55M |
| 2026-05-15 | -1.43 | -0.0102 | $1.67M | $7.14M |
Related companies
